InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: slcimmuno post# 119818

Monday, 08/24/2015 9:25:19 AM

Monday, August 24, 2015 9:25:19 AM

Post# of 403159
Combo treatment- any help? we have been talking about its importance for a while on the board.

Leo said in latest release that combo data is out for 1-renal 2-GBM 3 pancreatic 4 ovarian and 5 AML. The only problem is, that I cannot find any such data on the site, where he says it is, except for the mention that BIDMC did work with sunitinib and K (renal)and there was additional benefit. No hard data shown that I can see for renal and K, and NOTHING about any of the others, only the usual in vivo info for dug resistant tumors and K alone, in comparison with other agents, but not in combo.

As has been said, there is a lovely graph on the Aprea site showing benefit of cisplat + its drug for resistant ovarian ca.

there is nothing similar anywhere for K that I can find, even though he says its out there.

Any takers? Thanks for looking, I tried.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News